Physician profile
Andy C Lin
NPI 1336204031
$4,704.01
in general payments reported to CMS, 2019-2025
26 companies · $940 in 2025
The $940 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $427 · 2021: $540 · 2022: $1,504 · 2023: $387 · 2024: $649 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,976.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $911.01 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $776.43 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $557.70 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $438.71 | 2024-2025 | Jardiance, Ofev |
| Janssen Pharmaceuticals, INC | $334.13 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.00 | 2020-2025 | Lifevest |
| Boston Scientific Corporation | $235.10 | 2019-2025 | Watchman Flx, Farapulse, Latitude Communicator Power Supply |
| Astrazeneca Pharmaceuticals LP | $233.07 | 2020-2025 | Farxiga, Wainua, Lokelma |
| Heartflow, INC. | $192.59 | 2024-2025 | |
| Medtronic, INC. | $119.84 | 2021-2025 | Micra |
| Abbott Laboratories | $116.84 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $98.00 | 2022-2025 | Verquvo |
| Pfizer INC. | $82.84 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.93 | 2025 | |
| Amgen INC. | $38.17 | 2020-2025 | Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $36.57 | 2021 | |
| Biosense Webster, INC. | $31.78 | 2019 | |
| Tactile Systems Technology INC | $28.69 | 2024 | Flexitouch Plus, Entre Plus |
| Arbor Pharmaceuticals, INC. | $26.06 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $22.84 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $21.81 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $21.70 | 2024 | |
| Sanofi-Aventis U.S. LLC | $21.37 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $18.25 | 2024 | Arcalyst |
| Elutia, INC. | $16.90 | 2022 | |
| Terumo Medical Corporation | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.